71 South Wacker Drive,C/O Goldman Sachs & Co
Chicago , IL, 60606

Rank

Rank Universe
0 508

Summary

The fund seeks capital appreciation in the long term by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in securities of non-U.S. issuers.

For the process, the team employ More

Link

Directors

Jan 12, 2024
  • Gregory G. Weaver
  • James A. McNamara
  • John G. Chou
  • Paul C. Wirth
  • Dwight L. Bush
  • Eileen H. Dowling
  • Joaquin Delgado
  • Kathryn A. Cassidy

Chief Compliance Officer

  • Jessica Moran

Fund Manager(s)

Price

  • $ 14.12 ( +0.05 )
    Jan 17, 2025
    Last Close
  • Net Assets
  • $1.6B
    Mar 26, 2024
  • Holding
  • 309
    Sep 26, 2024
    More

  • 52-Week High/Low
  • $16.16 - $13.56
  • Turnover
  • 93%
  • Expense Ratio
  • 0.86%

Company Name

Holding

Novo Nordisk A/S 3.3 %
ASML Holding NV 2.82 %
Roche Holding AG 2.63 %
Nestle SA 2.53 %
Novartis AG 2.3 %
SAP SE 1.88 %
Schneider Electric SE 1.65 %
Munich Re 1.44 %
National Australia Bank Ltd 1.42 %
AstraZeneca PLC 1.35 %
More 1.35 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

19.86%

5 Year

7.05%

Best

17.4%

2023

Worst

-18.14%

2022

Alpha

GGFPX S&P 500

Chart +